Trilobatin alleviates non-alcoholic fatty liver disease in high-fat diet plus streptozotocin-induced diabetic mice by suppressing NLRP3 inflammasome activation
Zhi‐Tong Zhang, Wen-Jiao He, Simin Deng, Shuhong Xu, Xia Zeng, Zhengming Qian, Zhiquan Chen, Shumei Wang, Dan Tang
Topics & Concepts
PyroptosisInflammasomeFatty liverLipotoxicityLiver injuryInternal medicineEndocrinologyDiabetes mellitusMedicineInflammationStreptozotocinProinflammatory cytokineCaspase 1FibrosisInsulin resistanceDiseaseLiver Disease Diagnosis and TreatmentInflammasome and immune disordersDiet, Metabolism, and Disease